Defence Therapeutics Inc.: Defence Therapeutics to Finalize Its Objectives to Initiate a Phase I Trial Against Breast Cancer
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a biotechnology Company working on
United Kingdom British Columbia Sebastien Plouffe Defence Therapeutics Inc British Columbia Newsfile Corp Defence Therapeutics
Source: finanznachrichten.de